Private Placement

The fintech firm is pivoting hard into digital assets, planning to mine Bitcoin Cash while launching a novel crypto life insurance business in Bermuda.

Backed by a major investment from Nuveen, TurnClear launches to offer water 'Treatment-as-a-Service,' helping industries cut costs and meet regulations.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

With a new industrial leader, Lithium de France is accelerating its ambitious plan to supply one-third of the nation's lithium from geothermal sources.

Amid warnings of a funding cliff, the government is set to announce new support for women's groups. Will it be enough to ensure their long-term survival?

With the appointment of Kash Mohammed as President, intelliSPEC signals a major push to unify its platform and lead the AI revolution in industrial asset management.

Angel Oak Mortgage REIT declared a hefty $0.32 dividend, boasting a 14% yield. But can its earnings sustain the payout in the evolving non-QM market?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

Veteran investor Stephen Riddell partners with Gallatin Point to launch DS2 Capital, a new firm poised to navigate the complex structured credit market.

With a C$40M war chest, Helius Minerals aims to succeed where others failed, reviving one of history's richest and most notorious gold mines.

A new affordable housing project with a public park tackles Columbus's severe housing crisis, showcasing a model for public-private urban development.

Calgary-based energy firm nearly doubles its offering, signaling robust market confidence and fueling a major strategic acquisition in Alberta's Deep Basin.

A new report reveals a stark drop in profitability, but owners remain surprisingly optimistic, fueling a massive surge in demand for capital.

The Rainwater Foundation awards $600,000 to pioneering scientists, accelerating breakthroughs in treating devastating neurodegenerative tauopathies.

With a $375M facility from Eldridge, Atlas Energy is pivoting from proppant to power, aiming to solve the Permian Basin's growing energy crisis.

Initial results from a deep exploration project at Quebec's Gaspé Copper mine reveal a massive, high-grade copper zone, signaling a new chapter for the region.

With its lead drug MOLBREEVI under FDA review, Savara's upcoming investor talks are a critical test of its path from clinical trials to market.

A hidden pact diverting fees has ignited a corporate battle at CEA Industries, threatening its massive BNB treasury and exposing a web of conflicts.

Amid strong revenue growth, Capstone's focus on powering AI and datacenters takes center stage as investors await crucial Q3 financial results.